Helixmith Co., Ltd (084990.KQ)

KRW 2770.0

(0.0%)

Long Term Debt Summary of Helixmith Co., Ltd

Helixmith Co., Ltd's latest annual long term debt in 2023 was 151.68 Million KRW , down -73.43% from previous year.
Helixmith Co., Ltd's latest quarterly long term debt in 2024 Q2 was 151.68 Million KRW , down 0.0% from previous quarter.
Helixmith Co., Ltd reported annual long term debt of 570.79 Million KRW in 2022, down -97.17% from previous year.
Helixmith Co., Ltd reported annual long term debt of 20.17 Billion KRW in 2021, up 9761.58% from previous year.
Helixmith Co., Ltd reported quarterly long term debt of 151.68 Million KRW for 2024 Q2, down 0.0% from previous quarter.
Helixmith Co., Ltd reported quarterly long term debt of 594.86 Million KRW for 2023 Q1, up 4.22% from previous quarter.

Annual Long Term Debt Chart of Helixmith Co., Ltd (2023 - 2012)

Historical Annual Long Term Debt of Helixmith Co., Ltd (2023 - 2012)

Year	Long Term Debt	Long Term Debt Growth
2023	151.68 Million KRW	-73.43%
2022	570.79 Million KRW	-97.17%
2021	20.17 Billion KRW	9761.58%
2020	204.57 Million KRW	-99.82%
2019	115.04 Billion KRW	53.51%
2018	74.94 Billion KRW	567.98%
2017	11.21 Billion KRW	162.39%
2016	4.27 Billion KRW	687.78%
2015	542.75 Million KRW	0.0%
2013	668 Million KRW	-67.86%
2012	2.07 Billion KRW	0.0%

Year	Long Term Debt	Long Term Debt Growth
2024 Q1	151.68 Million KRW	0.0%
2024 Q2	151.68 Million KRW	0.0%
2023 Q1	594.86 Million KRW	4.22%
2023 FY	151.68 Million KRW	-73.43%
2023 Q4	151.68 Million KRW	0.0%
2023 Q3	151.68 Million KRW	0.0%
2023 Q2	151.68 Million KRW	-74.5%
2022 Q3	23.17 Billion KRW	0.01%
2022 Q2	23.17 Billion KRW	0.01%
2022 Q1	23.17 Billion KRW	14.88%
2022 FY	570.79 Million KRW	-97.17%
2022 Q4	570.79 Million KRW	-97.54%
2021 Q3	173.18 Million KRW	14.18%
2021 Q1	171.24 Million KRW	-97.4%
2021 FY	20.17 Billion KRW	9761.58%
2021 Q2	151.68 Million KRW	-11.43%
2021 Q4	20.17 Billion KRW	11548.82%
2020 Q4	6.58 Billion KRW	-91.53%
2020 Q3	77.79 Billion KRW	-0.41%
2020 Q1	126.7 Billion KRW	2.14%
2020 Q2	78.11 Billion KRW	-38.35%
2020 FY	204.57 Million KRW	-99.82%
2019 Q1	94.44 Billion KRW	26.03%
2019 FY	115.04 Billion KRW	53.51%
2019 Q4	124.04 Billion KRW	18.42%
2019 Q3	104.74 Billion KRW	-6.91%
2019 Q2	112.52 Billion KRW	19.14%
2018 Q3	70.77 Billion KRW	527.38%
2018 Q1	11.22 Billion KRW	0.09%
2018 FY	74.94 Billion KRW	567.98%
2018 Q4	74.94 Billion KRW	5.88%
2018 Q2	11.28 Billion KRW	0.47%
2017 Q4	11.21 Billion KRW	0.0%
2017 FY	11.21 Billion KRW	162.39%
2016 FY	4.27 Billion KRW	687.78%
2015 FY	542.75 Million KRW	0.0%
2014 Q3	716.58 Million KRW	-8.76%
2014 Q2	785.4 Million KRW	17.57%
2014 Q1	668 Million KRW	-0.0%
2013 Q3	443 Million KRW	-4.08%
2013 Q1	2.46 Billion KRW	18.36%
2013 Q2	461.83 Million KRW	-81.23%
2013 Q4	668 Million KRW	50.79%
2013 FY	668 Million KRW	-67.86%
2012 FY	2.07 Billion KRW	0.0%
2012 Q4	2.07 Billion KRW	0.0%

Peer Long Term Debt Comparison of Helixmith Co., Ltd

Name	Long Term Debt	Long Term Debt Difference
HLB Co., Ltd.	17.93 Billion KRW	99.154%
iNtRON Biotechnology, Inc.	258.29 Million KRW	41.276%
BINEX Co., Ltd.	5.57 Billion KRW	97.281%
Bioneer Corporation	12.5 Billion KRW	98.787%
Anterogen.Co.,Ltd.	- KRW	-Infinity%
MEDIPOST Co., Ltd.	6.99 Billion KRW	97.832%
CrystalGenomics, Inc.	29.88 Billion USD	99.493%
Chabiotech Co.,Ltd.	95.06 Billion KRW	99.84%
Medy-Tox Inc.	1.22 Billion KRW	87.626%
Peptron, Inc.	4.5 Billion KRW	96.629%
Amicogen, Inc.	70.65 Billion KRW	99.785%
Genexine, Inc.	22.68 Billion KRW	99.331%
HLB Therapeutics Co.,Ltd.	1.84 Billion KRW	91.757%
LegoChem Biosciences, Inc.	528.37 Million KRW	71.293%
ALTEOGEN Inc.	1.24 Billion KRW	87.858%
PharmaResearch Co., Ltd.	970.71 Million KRW	84.374%
SillaJen, Inc.	8.13 Billion KRW	98.136%
JETEMA, Co., Ltd.	60 Billion KRW	99.747%
OliX Pharmaceuticals,Inc	35.36 Billion KRW	99.571%
Genomictree Inc.	97.51 Million KRW	-55.544%
MedPacto, Inc.	1.68 Billion KRW	91.009%
D&D Pharmatech	5.12 Billion KRW	97.038%
EASY BIO,Inc.	30 Billion KRW	99.494%
GI Innovation, Inc.	2.9 Billion KRW	94.777%